Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
  • A61Q19/08—Anti-ageing preparations
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
  • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
  • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
  • A61K8/988—Honey; Royal jelly, Propolis
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin

Definitions

• the invention relates to a cosmetic or dermatological composition containing honey as a keratolytic agent and a method of applying same for improving the radiance of the complexion, smoothing the skin of the human face or body, or for treating wrinkles and fine lines. It also relates to a topical composition containing honey and at least one fatty alcohol. It relates also to a topical composition containing honey and at least one hydroxy acid, which composition is buffered at pH 5 and makes it possible to gently combat the ageing of the skin of the human face and/or body.
• honey exhibits keratolytic properties and makes it possible to improve the radiance of the complexion of the skin and to smooth the features of the skin, thus causing the skin to appear younger and less wrinkled.
• Honey has been used in cosmetic compositions intended for the treatment of ageing; see, for example, JP-A-59-55809, GB-A-120,673 and JP-A-6-38702.
• the honey is added as an additive to the active ingredients, which are active with respect to ageing, and its own effectiveness as keratolytic agent has never been described or realized.
• One object of the present invention is consequently to provide a cosmetic composition and a method for improving the radiance of the complexion, for smoothing the skin, and for treating wrinkles and fine lines.
• Another object of the invention is to provide a keratolytic agent for improving the radiance of the complexion, for smoothing the skin, and treating wrinkles and fine lines suitable for a dermatological composition.
• Another object of the invention is a cosmetic and/or dermatological process for treating wrinkles, fine lines of the skin, and the visible signs of ageing.
• Another object of the present invention is to gently combat the ageing or the visible signs of ageing of the skin of the human face or body using a keratolytic agent.
• composition that contains honey as the keratolytic agent.
• a keratolytic effective amount of honey as the sole keratolytic effective agent
• the second embodiment of the present invention is to provide a keratolytic composition, including:
• At least one acidic active agent selected from the group consisting of ⁇ -hydroxy acid, ⁇ -hydroxy acid, ⁇ -keto acid, ⁇ -keto acid, and a mixture thereof;
• the third embodiment of the present invention is to provide a method for inducing keratolytic activity in skin, including:
• composition including a keratolytic effective amount of honey.
• the fourth embodiment of the present invention is to provide a method for treating wrinkles, fine lines, and the visible signs of ageing, including:
• composition including a keratolytic effective amount of honey.
• the fifth embodiment of the present invention is to provide a method for improving the radiance of the complexion, including:
• composition including a keratolytic effective amount of honey.
• Honey is understood to mean an untreated honey, that is to say not fermented and not containing hydroxy acids, in contrast to the honey extract which is a fermentation product and which contains hydroxy acids.
• the honey used according to the invention is preferably composed of a mixture of glucose, levulose, dextrin, sucrose, proteins and water, it being possible for the content of these various constituents to vary depending on the origin of the honey.
• Honey conventionally includes from 72 to 75% of the mixture of glucose and levulose, 15% water, 10% dextrin, 2.5% sucrose and 1% proteins.
• the honey can have any origin.
• it can be an acacia honey, a lime honey, a mountain honey, a Gatinais's honey, an orange blossom honey or a honey derived from all kinds of flowers.
• the amount of honey in the composition according to the invention must be in an effective amount so as to act as keratolytic agent and can range, for example, from 0.1 to 10%, preferably 0.1 to 5%, and more preferably from 0.1 to 2% of the total weight of the composition. These ranges include all values and subranges therebetween.
• the composition contains, in addition to honey, at least one fatty alcohol which makes it possible to improve stability of the composition.
• fatty alcohol of cetyl alcohol and stearyl alcohol.
• the amount of fatty alcohol can range, for example, from 0.1 to 10% and preferably from 0.5 to 5% of the total weight of the composition. These ranges include all values and subranges therebetween.
• the present invention is a cosmetic or dermatological composition that contains, in a cosmetically and/or dermatologically acceptable medium, an effective amount of honey and at least one fatty alcohol.
• the composition contains, in addition to honey, one or a number of acidic active agent and a buffer of pH 5.
• honey one or a number of acidic active agent and a buffer of pH 5.
• the inventors have found, surprisingly, that such a composition reduces the irritant effect of the acidic active agent without decreasing the activity of these active agents.
• the simultaneous presence of honey, of acidic active agent and of the buffer makes it possible to obtain a composition having a particularly satisfactory tolerance/effectiveness relationship.
• the present invention is consequently a cosmetic or dermatological composition containing, in a cosmetically and/or dermatologically acceptable medium, at least one acidic active agent that additionally contains honey and a buffer of pH 5.
• acidic active agents which can be used in the composition of the invention, of ⁇ -hydroxy acids or ⁇ -hydroxy acids, or a mixture thereof, which can be linear, branched or cyclic and saturated or unsaturated.
• the hydrogen atoms of the carbon chain can be substituted by halogens or halogenated, alkyl, acyl, acyloxy, alkoxycarbonyl or alkoxy radicals having from 2 to 18 carbon atoms.
• salicylic acid derivative of those described in the documents FR-A-2,581,542 and EP-A-3,378,936, the entire contents of which are hereby incorporated by reference, and in particular of 5-(n-octanoyl)salicylic, 5-(n-decanoyl)salicylic, 5-(n-dodecanoyl)salicylic, 5-(n-octyl)salicylic, 5-(n-heptyloxy)salicylic and 4-(n-heptyloxy)salicylic acids. It is also possible to use those described in the document EP-A-570,230, the entire contents of which are hereby incorporated by reference.
• the amount of acidic active agent can range from 0.01 to 20% and preferably from 0.1 to 5% of the total weight of the composition. These ranges include all values and subranges therebetween.
• the buffered composition according to the invention its pH is adjusted to 5, or about 5, using bases, such as sodium hydroxide or triethanolamine, and then the buffer of pH 5 is added.
• bases such as sodium hydroxide or triethanolamine
• the buffer present in the composition according to the invention is not particularly limited, but can be in particular a citrate buffer of pH 5.
• the amount of buffer present in the composition can range, for example, from 0.1 to 10% and preferably from 0.5 to 3% of the total weight of the composition. These ranges include all values and subranges therebetween.
• composition defined above is capable of treating the skin gently, that is to say of improving the radiance of the complexion, of smoothing the skin and of treating wrinkles and/or fine lines of the skin.
• a further object of the present invention is consequently the cosmetic use of the compositions defined above for improving the radiance of the complexion and/or for smoothing the skin and/or treating wrinkles and fine lines of the skin.
• the composition of the invention containing honey includes a cosmetically and/or dermatologically acceptable medium, that is to say compatible with the skin, the scalp and the hair.
• a cosmetically and/or dermatologically acceptable medium that is to say compatible with the skin, the scalp and the hair.
• It can be provided in all the pharmaceutical dosage forms normally used for a topical application, in particular in the form of an aqueous, aqueous/alcoholic or oily solution, of an oil-in-water or water-in-oil or multiple emulsion, of an aqueous or oily gel, of a liquid, pasty or solid anhydrous product or of a dispersion of oil in an aqueous phase with the use of spherules, it being possible for these spherules to be polymeric nanoparticles, such as nanospheres and nanocapsules, or better still lipid vesicles of ionic and/or non-ionic type.
• This composition can be more or less fluid and have the appearance of a white or coloured cream, of an ointment, of a milk, of a lotion, of a serum, of a paste or of a foam. It can optionally be applied on the skin in the aerosol form. It can also be provided in the solid form and, for example, in the stick form. It can be used as care product, as cleansing product or alternatively as make-up product.
• the composition of the invention can also contain adjuvants generally known in the cosmetic and dermatological fields, such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active principles, preservatives, antioxidants, solvents, fragrances, fillers, screening agents, pigments, chelating agents, odour absorbers and colouring materials.
• adjuvants generally known in the cosmetic and dermatological fields, such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active principles, preservatives, antioxidants, solvents, fragrances, fillers, screening agents, pigments, chelating agents, odour absorbers and colouring materials.
• the amounts of these various adjuvants are those conventionally used in the fields under consideration and, for example, from 0.01 to 20% of the total weight of the composition, preferably 0.1 to 20%, more preferably 1 to 10%, and most preferably 2 to 5% by weight of the composition. These ranges include all values and subranges therebetween.
• These adjuvants depending on their nature,
• the proportion of the fatty phase can range from 5 to 80% by weight and preferably from 5 to 50% of the total weight of the composition.
• the oils, the emulsifiers and the coemulsifiers used in the composition in the emulsion form are chosen from those conventionally used in the field under consideration.
• the emulsifier and the coemulsifier are present in the composition in a proportion ranging from 0.3 to 30% by weight and preferably from 0.5 to 20% of the total weight of the composition.
• the above ranges include all values and subranges therebetween.
• oils which can be used in the invention are mineral oils, oils of plant origin (apricot oil, sunflower oil), oils of animal origin, synthetic oils, silicone oils (cyclomethicone) and fluorinated oils (perfluoropolyethers).
• oils which can be used in the invention, are mineral oils, oils of plant origin (apricot oil, sunflower oil), oils of animal origin, synthetic oils, silicone oils (cyclomethicone) and fluorinated oils (perfluoropolyethers).
• Use may also be made, as fatty substances, of fatty alcohols (cetyl alcohol), fatty acids or waxes (beeswax).
• esters of fatty acid and of polyethylene glycol such as PEG-40 stearate or PEG-100 stearate
• esters of fatty acid and of polyol such as glyceryl stearate and sorbitan tristearate.
• hydrophilic gelling agents are carboxyvinyl (carbomer) polymers, acrylic copolymers, such as acrylate/alkyl acrylate copolymers, polyacrylamides, polysaccharides, natural gums and clays and mention may be made, as lipophilic gelling agents, of modified clays, such as bentones, metal salts of fatty acids, hydrophobic silica and polyethylenes.
• carboxyvinyl (carbomer) polymers acrylic copolymers, such as acrylate/alkyl acrylate copolymers, polyacrylamides, polysaccharides, natural gums and clays and mention may be made, as lipophilic gelling agents, of modified clays, such as bentones, metal salts of fatty acids, hydrophobic silica and polyethylenes.
• moisturizers such as polyols (for example glycerol), vitamins (for example D-panthenol), anti-inflammatory agents, soothing agents (allantoin, cornflower water), UVA and UVB screening agents, mattifying agents (for example the partially crosslinked polydimethylorganosiloxanes sold under the name KSG by Shin Etsu), and their mixtures.
• polyols for example glycerol
• vitamins for example D-panthenol
• anti-inflammatory agents for example D-panthenol
• soothing agents allantoin, cornflower water
• UVA and UVB screening agents for example the partially crosslinked polydimethylorganosiloxanes sold under the name KSG by Shin Etsu
• mattifying agents for example the partially crosslinked polydimethylorganosiloxanes sold under the name KSG by Shin Etsu
• anti-wrinkle active agents other than honey, and preferably tensioning products such as plant proteins and their hydrolysates, more preferably the soya protein extract sold under the name of Eleseryl by the company LSN or the oats derivative sold under the name "Reductine” by the company Silab.
• the aqueous and oily phases are heated separately to 70-80° C.
• the oily phase is then introduced into the aqueous phase at 65° C. with stirring.
• the emulsion is cooled to room temperature while continuing to stir.
• a white cream is obtained which is capable of restoring radiance to the skin of the face.
• the results show that the keratolytic effect of the cream according to the invention is equivalent to that obtained with the cream containing the fruit acids.
• the cream according to the invention has the advantage of being less irritating than the creams containing acidic active agents, although as effective.
• the oily phase is melted at 75° C. and the aqueous phase is heated to 80° C.
• the emulsion is then prepared by introducing the oily phase into the aqueous phase at 75° C. with stirring. The mixture is cooled to room temperature while continuing to stir.
• a test of effectiveness of this cream was carried out on a panel of 30 women. These women applied the cream on the face once a day for five days. 96% of the users found that the cream was very comfortable, even after applying for five days. Moreover, after the five days of use, 69% of the users found that they had a better appearance, 62% that their complexion was less muddy and 69% that they had a smoother skin.
• this cream was judged as effective and less irritating.
• Example 2 The procedure followed for the preparation of this fluid is the same as in Example 2.
• the test of effectiveness of this fluid was carried out on a panel of 60 women who have sensitive skins. These women applied the fluid on the face once a day for five weeks. At the end of this application period, 59% of the users were found to be satisfied with the product, 56% noticed an effect of radiance of the complexion and 62% found that they had a smoother skin.
• this fluid was judged as effective as a product containing 1.4% of a mixture of fruit acids, while being less irritating.
• the aqueous phase is heated to 80° C. in order to dissolve the preservatives; mixing is carried out and then the mixture is cooled to room temperature.
• the oily phase is prepared at room temperature. The two phases are mixed and homogenized.
• a two-phase lotion is obtained which is shaken before use and which, at rest, again separates into two phases.
• This lotion on daily application on the face, makes it possible to regain a radiant complexion.
• the preservatives are heated in water at 80° C. in order to dissolve them.
• the other constituents are then added.
• the combined constituents are mixed well.
• a transparent lotion is obtained which has toning and regenerating properties.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Dermatology (AREA)
• Zoology (AREA)
• Birds (AREA)
• Epidemiology (AREA)
• Gerontology & Geriatric Medicine (AREA)
• Cosmetics (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=9494536

Family Applications (1)

Country Status (5)

Cited By (10)

Families Citing this family (22)

Citations (4)

Family Cites Families (8)

• 1996
  • 1996-07-26 FR FR9609458A patent/FR2751537B1/fr not_active Expired - Fee Related
• 1997
  • 1997-07-02 EP EP97401559A patent/EP0820765A3/fr not_active Withdrawn
  • 1997-07-24 JP JP09199026A patent/JP3112436B2/ja not_active Expired - Fee Related
  • 1997-07-25 BR BR9702662A patent/BR9702662A/pt not_active Application Discontinuation
  • 1997-07-28 US US08/901,522 patent/US5965145A/en not_active Expired - Lifetime

Patent Citations (4)

Non-Patent Citations (9)

Also Published As

Similar Documents

Legal Events